Experience of use of the anti-cytokine drug adalimumab in children with polyarticular seronegative junior arthritis living in the Samara region
Background. Juvenile idiopathic arthritis is the most common rheumatic disease in childhood. Adalimumab is the drug of choice for polyarthritis, HLA-B27-associated arthritis, psoriatic arthritis, as well as for the association of arthritis with enthesitis, uveitis. It is of interest to evaluate the...
| Published in: | Лечащий Врач |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2023-10-01
|
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/1122 |